Emergent Biosolutions Inc.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

13.18%

Market Cap

461.04 Mil.

P/E Ratio

13.32

Dividend Yield

0.00 %

Earnings per Share

0.82 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE6.685 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:46:28 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW6.7056.61
PREV. DAY'S PRICE6.705 (07/20)
CHANGE DAY BEFORE
-0.02
-0.30 %
52 WEEK HIGH / LOW11.94 (01/07)4.828 (08/04)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
-13.74-3.320.820.280.80
DIVIDENDS PER SHARE
0.000.000.00--
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
--13.3223.488.38
PRICE - BOOK RATIO
0.191.081.23--
PRICE - SALES RATIO
0.120.490.94--
PRICE - CASH FLOW RATIO
-8.634.11--
Further Key Figures

Master Data

WKN
A0LC2W
ISIN
US29089Q1058
SYMBOL
ER4
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
EMERGENT BIOSOLNS DL-,001
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
52.20 Mil.
MARKET CAPITALISATION
461.04 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-4.83 %
-2.69 %
-4.83 %
-28.84 %
13.18 %
6.26 %
-87.76 %
-34.43 %
HIGH6.967.508.1410.6511.9413.8055.3611.94
LOW6.476.476.476.474.831.351.356.47

Dividende

pro Aktie
EMERGENT BIOSOLNS DL-,001 does not deliver dividend information

Company profile

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.